BC
AZN icon

Bartlett & Co’s AstraZeneca AZN Stock Holding History

Bartlett & Co’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$106K Buy
790
+394
+99% +$51.2K ﹤0.01% 568
2023
Q3 		$54K Hold
396
– – ﹤0.01% 655
2023
Q2 		$57K Buy
396
+84
+27% +$12.4K ﹤0.01% 643
2023
Q1 		$43K Hold
312
– – ﹤0.01% 590
2022
Q4 		$42K Hold
312
– – ﹤0.01% 606
2022
Q3 		$34K Hold
312
– – ﹤0.01% 622
2022
Q2 		$41K Hold
312
– – ﹤0.01% 599
2022
Q1 		$41K Buy
+312
New +$37.4K ﹤0.01% 617
2021
Q4 		– Sell
-312
Closed -$37K – 440
2021
Q3 		$37K Buy
312
+14
+5% +$1.63K ﹤0.01% 548
2021
Q2 		$36K Hold
298
– – ﹤0.01% 549
2021
Q1 		$30K Hold
298
– – ﹤0.01% 613
2020
Q4 		$30K Buy
298
+21
+8% +$2.22K ﹤0.01% 608
2020
Q3 		$30K Buy
277
+50
+22% +$5.56K ﹤0.01% 561
2020
Q2 		$24K Sell
227
-12
-5% -$1.24K ﹤0.01% 591
2020
Q1 		$21K Buy
+239
New +$22.5K ﹤0.01% 573
2019
Q3 		$20K Buy
+227
New +$19.7K ﹤0.01% 652
2019
Q2 		– Sell
-33
Closed -$3K – 730
2019
Q1 		$3K Sell
33
-767
-96% -$60.5K ﹤0.01% 632
2018
Q4 		$61K Hold
800
– – ﹤0.01% 377
2018
Q3 		$63K Buy
+800
New +$60.5K ﹤0.01% 404
2015
Q1 		– Sell
-1,155
Closed -$81K – 720
2014
Q4 		$81K Buy
1,155
+130
+13% +$9.31K ﹤0.01% 345
2014
Q3 		$73K Hold
1,025
– – ﹤0.01% 353
2014
Q2 		$76K Sell
1,025
-75
-7% -$5.42K ﹤0.01% 355
2014
Q1 		$71K Buy
1,100
+1,025
+1,367% +$66.2K ﹤0.01% 364
2013
Q4 		$4K Hold
75
– – ﹤0.01% 631
2013
Q3 		$4K Hold
75
– – ﹤0.01% 661
2013
Q2 		$4K Buy
+75
New +$3.82K ﹤0.01% 658

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bartlett & Co's AZN Position: Q4 2023 in Review

Bartlett & Co increased its AstraZeneca (AZN) stake by 99% in Q4 2023, buying an estimated $51.2K and bringing the position to 790 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #568.

Bartlett & Co first reported a position in AZN in Q2 2013 and has held it in 26 quarters since. 1,130 funds tracked by Wall St. Rank hold AZN as of Q4 2023.

  • Bartlett & Co held 790 shares of AstraZeneca worth $106K as of Q4 2023.
  • Bartlett & Co bought 394 AstraZeneca shares in Q4 2023, an estimated $51.2K.
  • AstraZeneca made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #568 holding.
  • Bartlett & Co first reported a position in AstraZeneca in Q2 2013 and has held it in 26 quarters since.
  • 1,130 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.